The urokinase plasminogen activator system in metastatic papillary thyroid carcinoma: a potential therapeutic target

about

The urokinase plasminogen activator system in metastatic papillary thyroid carcinoma: a potential therapeutic target

Item

http://www.wikidata.org/entity/Q36158388

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

The urokinase plasminogen acti ...... a potential therapeutic target

@ast

The urokinase plasminogen acti ...... a potential therapeutic target

@en

type

Item

label

The urokinase plasminogen acti ...... a potential therapeutic target

@ast

The urokinase plasminogen acti ...... a potential therapeutic target

@en

prefLabel

The urokinase plasminogen acti ...... a potential therapeutic target

@ast

The urokinase plasminogen acti ...... a potential therapeutic target

@en

P1476

The urokinase plasminogen acti ...... a potential therapeutic target

@en

P2093

Augustine L Moscatello

http://www.w3.org/2001/XMLSchema#string

Edward Shin

http://www.w3.org/2001/XMLSchema#string

Jan Geliebter

http://www.w3.org/2001/XMLSchema#string

Raj K Tiwari

http://www.w3.org/2001/XMLSchema#string

Stimson Schantz

http://www.w3.org/2001/XMLSchema#string

Theodore S Nowicki

http://www.w3.org/2001/XMLSchema#string

P2860

Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma.

Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells.

Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib.

Regulation of cell signalling by uPAR.

Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells.

Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E.

Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.

Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience.

P304

3062-3064

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2011-1123

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51562325

http://www.w3.org/2001/XMLSchema#string

P698

21832115

http://www.w3.org/2001/XMLSchema#string

P932

3417282

http://www.w3.org/2001/XMLSchema#string